RNA sequencing is increasingly being employed in clinical studies. During data pre-processing, samples are typically excluded from further analysis based on quality metrics that assess the integrity of the intermediate genomic product. RNA degradation may occur during sample handling as well as necrosis, affecting tissues in people with necrotising soft tissue infections (NSTIs).
RNA integrity measured with RNA Quality Number (RQN) and Transcript Integrity Number (TIN) in infected tissue samples may be lower in severe cases of NSTI.
We analysed whole blood and infected tissue samples from 95 individuals with acute NSTI and evaluated RNA integrity using RQN and TIN. Using linear models, we examined their relationships with age, BMI, RNA quantity, Sequential Organ Failure Assessment (SOFA) score, plasma lactate level (blood), and tissue type (infected tissue).
In infected tissue samples, we discovered that for every 5-point increase in SOFA score, the RQN increased by 0.19 points, 95 % CI [0.15, 1.80], p = 0.022, but there was no influence on the TIN. In blood, we observed no associations between RQN and SOFA or raised lactate levels, nor between TIN and SOFA score or elevated lactate. In both tissues, we discovered a link between age and RNA integrity measurements, and that RQN was dependent on the RNA quantity extracted from samples.
We advocate using numerous integrity measures to evaluate RNA integrity. Samples should not be removed based on any integrity measures in data pre-processing. The biological and technological implications of eliminating samples should be assessed using the integrity metrics as covariates.
扫码关注我们
求助内容:
应助结果提醒方式:
